OVARIAN-CYST FORMATION IN 2 PREMENOPAUSAL PATIENTS TREATED WITH TAMOXIFEN FOR BREAST-CANCER

被引：26
|
作者：
SHULMAN, A [1 ]
COHEN, I [1 ]
ALTARAS, MM [1 ]
MAYMON, R [1 ]
BENNUN, I [1 ]
TEPPER, R [1 ]
BEYTH, Y [1 ]
机构：
[1] TEL AVIV UNIV,ASSAF HAROFE HOSP,SACKLER SCH MED,DEPT OBSTET & GYNAECOL,RAMAT AVIV,ISRAEL
来源：
HUMAN REPRODUCTION | 1994年 / 9卷 / 08期
关键词：
BREAST CANCER; GNRH; ESTROGENS; PRE-MENOPAUSE; TAMOXIFEN;
D O I：
10.1093/oxfordjournals.humrep.a138723
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Pre-menopausal tamoxifen treatment causes hyperoestrogen production and ovarian cyst formation. Two pre-menopausal breast cancer patients who were treated with tamoxifen developed both permanent supraphysiological oestrogen concentration and ovarian cysts. Serum oestrogen decreased to post-menopausal concentrations and ovarian cysts completely resolved during and following simultaneous treatment with tamoxifen and gonadotrophin-releasing hormone agonist (GnRHa). In pre-menopausal breast cancer patients, GnRHa may prevent possible side-effects of tamoxifen, such as ovarian cysts and supraphysiological oestrogen production.
引用
收藏
页码：1427 / 1429
页数：3
相关论文
共 50 条
  • [31] EFFECTS OF CYTOTOXIC CHEMOTHERAPY ON OVARIAN AND ADRENAL STEROIDOGENESIS IN PREMENOPAUSAL BREAST-CANCER PATIENTS
    DOWSETT, M
    RICHNER, J
    ONCOLOGY, 1991, 48 (03) : 215 - 220
  • [32] ADENOMYOSIS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN - A NEW ENTITY
    COHEN, I
    BEYTH, Y
    TEPPER, R
    FIGER, A
    SHAPIRA, J
    CORDOBA, M
    YIGAEL, D
    ALTARAS, MM
    GYNECOLOGIC ONCOLOGY, 1995, 58 (01) : 86 - 91
  • [33] HORMONES IN BREAST-CANCER PATIENTS ON TAMOXIFEN
    GOLDER, MP
    PHILLIPS, MEA
    BAUM, M
    GRIFFITHS, K
    FAHMY, DR
    HENK, JM
    JONES, V
    PREECE, PE
    BRITISH JOURNAL OF CANCER, 1975, 32 (02) : 246 - 247
  • [34] Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen
    Lee, Maria
    Piao, Jinlan
    Jeon, Myung Jae
    YONSEI MEDICAL JOURNAL, 2020, 61 (04) : 317 - 322
  • [35] TAMOXIFEN THERAPY AND SUBSEQUENT OVARIAN, ENDOMETRIAL, AND BREAST-CANCER
    COOK, L
    WEISS, N
    SCHWARTZ, S
    WHITE, E
    MCKNIGHT, B
    MOORE, D
    DALING, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (11) : S11 - S11
  • [36] Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysis
    Azim, Hamdy A.
    Shohdy, Kyrillus S.
    Kaldas, David F.
    Kassem, Loay
    Azim, Hatem A., Jr.
    CURRENT PROBLEMS IN CANCER, 2020, 44 (06)
  • [37] NEONATAL OVARIAN-CYST DIAGNOSED ANTENATALLY - REPORT OF 2 PATIENTS
    SUITA, S
    KOYANAGI, T
    NAKANO, H
    JOURNAL OF CLINICAL ULTRASOUND, 1984, 12 (08) : 517 - 519
  • [38] FREE TESTOSTERONE IN PREMENOPAUSAL BREAST-CANCER PATIENTS
    RECCHIONE, G
    BALLERINI, P
    SECRETO, G
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1990, 595 : 484 - 486
  • [39] GYNECOLOGICAL COMPLICATIONS OF WOMEN TREATED WITH TAMOXIFEN FOR BREAST-CANCER
    DEW, JE
    EDEN, JA
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1995, 35 (02): : 198 - 200
  • [40] Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifen
    Nasu, K
    Miyazaki, T
    Kiyonaga, Y
    Kawasaki, F
    Miyakawa, I
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 48 (03) : 200 - 202
12345